SG Micro Corp
300661
Shanghai Cooltech Power
300153
Shenzhen Qingyi Photomask
688138
YD Electronic Technology
301123
Hunan Sundy Science And Technology
300515
CN Stock MarketDetailed Quotes
300584 Nanjing Hicin Pharmaceutical
- 19.65
- -0.08-0.41%
Market Closed Jan 17 15:00 CST
2.36BMarket Cap56.14P/E (TTM)
19.79High19.45Low12.27KlotVolume19.71Open19.73Pre Close24.08MTurnover1.50%Turnover Ratio64.85P/E (Static)120.00MShares27.9352wk High2.33P/B1.61BFloat Cap12.6352wk Low23.68Limit Up82.12MShs Float87.10Historical High15.78Limit Down1.72%Amplitude7.65Historical Low0.05Dividend TTM19.62Avg Price7.36KlotAsk0.25%Div YieldTTM100Lot Size4.56KlotBid
Nanjing Hicin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.62%360.5M | -9.56%236.53M | -10.78%104.56M | -1.64%517.83M | -0.33%377.95M | -2.25%261.55M | -22.18%117.2M | -8.97%526.47M | -16.38%379.21M | -15.56%267.58M |
| Operating revenue | -4.62%360.5M | -9.56%236.53M | -10.78%104.56M | -1.64%517.83M | -0.33%377.95M | -2.25%261.55M | -22.18%117.2M | -8.97%526.47M | -16.38%379.21M | -15.56%267.58M |
| Other operating revenue | ---- | 18.50%1.07M | ---- | -50.28%1.85M | ---- | -63.28%905.86K | ---- | -50.37%3.73M | ---- | -17.50%2.47M |
| Total operating cost | -7.49%324.03M | -13.66%205.03M | -16.25%85.58M | -3.04%475.39M | -0.59%350.26M | -2.46%237.47M | -23.70%102.19M | -11.42%490.31M | -16.77%352.35M | -17.61%243.46M |
| Operating cost | -11.90%60.91M | -17.06%37.52M | -10.23%18.68M | -25.71%96.59M | -25.98%69.14M | -32.13%45.23M | -48.07%20.81M | 19.27%130.02M | 14.06%93.41M | 16.23%66.64M |
| Operating tax surcharges | -5.31%7.94M | -5.81%5.36M | -8.84%2.42M | 15.60%11.29M | 16.01%8.39M | 18.83%5.69M | 5.39%2.65M | -21.71%9.77M | -23.97%7.23M | -26.70%4.79M |
| Operating expense | -16.44%150.43M | -22.46%95.58M | -35.36%38.6M | -10.09%241.6M | -3.42%180.03M | -4.34%123.27M | -11.03%59.71M | -21.63%268.71M | -30.14%186.39M | -30.55%128.86M |
| Administration expense | 13.90%63.62M | 15.10%42.28M | 28.85%18.42M | 25.53%71.92M | 21.31%55.86M | 28.00%36.74M | -18.01%14.3M | -5.47%57.29M | 10.23%46.05M | 8.66%28.7M |
| Financial expense | 38.34%6.85M | 44.17%4.55M | 19.12%2.04M | 16.55%7.36M | 1.75%4.95M | -7.52%3.16M | -14.62%1.72M | -7.56%6.31M | 1.78%4.87M | 9.81%3.41M |
| -Interest expense (Financial expense) | 3.02%6.82M | 20.45%4.59M | 8.45%2.07M | 14.06%8.27M | 17.75%6.62M | -3.72%3.81M | -14.80%1.91M | -3.27%7.25M | 8.03%5.62M | 15.27%3.96M |
| -Interest Income (Financial expense) | 88.98%-94.12K | 88.84%-73.47K | 78.21%-44.88K | 5.38%-960.84K | -1.46%-854.06K | -7.09%-658.4K | 22.24%-205.93K | -30.21%-1.02M | -71.97%-841.74K | -65.80%-614.8K |
| Research and development | 7.42%34.27M | -15.57%19.74M | 80.20%5.43M | 155.99%46.63M | 121.45%31.9M | 111.45%23.38M | -37.09%3.01M | -16.04%18.22M | -22.59%14.41M | -33.27%11.06M |
| Credit Impairment Loss | 262.64%1.19M | 560.27%813.95K | -74.99%206.02K | 62.95%-1.68M | 113.50%327.99K | 108.92%123.27K | 172.74%823.81K | -235.43%-4.53M | -111.23%-2.43M | -195.50%-1.38M |
| Asset Impairment Loss | -10.02%-6.81M | 4.63%-4.39M | -71.03%-3.12M | -24.10%-4.68M | -167.14%-6.19M | -144.93%-4.6M | 24.99%-1.82M | -311.35%-3.77M | -129.39%-2.32M | -490.49%-1.88M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | --0.01 | ---0.01 | ---- | ---- | ---- | ---- |
| Other net revenue | -41.97%-5.11M | -9.05%-3.17M | -562.07%-2.64M | 47.98%-3.15M | -12.24%-3.6M | -16.52%-2.91M | 86.94%-399.39K | -101.98%-6.05M | -1,324.61%-3.21M | -299.93%-2.49M |
| Fair value change income | -97.26%1.71K | ---- | ---- | -93.08%64.18K | -93.07%62.37K | -90.37%58.52K | ---- | -99.70%927.86K | 235.39%900.02K | 467.64%607.99K |
| Invest income | ---120.41K | ---28.02K | ---105 | -2,054.13%-24.37K | ---- | ---- | ---- | 101.24%1.25K | -17.19%-117.76K | 21.68%-78.7K |
| Asset deal income | -115.26%-52.41K | -107.34%-25.2K | ---- | 16.84%-791.83K | 136.07%343.41K | 138.66%343.41K | 100.31%1.43K | -4,224.11%-952.18K | ---952.18K | ---888.31K |
| Other revenue | -63.29%681.47K | -60.74%460.08K | -55.16%268.52K | 74.70%3.96M | 8.55%1.86M | 4.06%1.17M | 7.22%598.85K | -7.66%2.27M | -3.24%1.71M | -8.23%1.13M |
| Operating profit | 30.19%31.36M | 33.79%28.33M | 11.78%16.34M | 30.53%39.29M | 1.82%24.09M | -2.08%21.18M | 7.27%14.61M | -90.91%30.1M | -20.97%23.66M | -4.51%21.63M |
| Add:Non operating Income | -89.51%24.26K | -95.22%11.49K | -99.34%150.2 | 38.78%239.83K | 43.35%231.26K | 94.12%240.38K | -76.38%22.67K | 186.50%172.82K | 1,123.98%161.32K | 968.43%123.83K |
| Less:Non operating expense | -13.39%1.18M | -14.52%957.65K | -94.04%62.15K | 23.04%1.84M | 34.49%1.36M | 398.99%1.12M | 48,993.61%1.04M | 64.06%1.5M | 13.42%1.01M | -65.51%224.52K |
| Total profit | 31.56%30.21M | 34.93%27.39M | 19.71%16.27M | 30.97%37.69M | 0.67%22.96M | -5.71%20.3M | -0.91%13.59M | -91.29%28.78M | -21.51%22.81M | -2.20%21.52M |
| Less:Income tax cost | 287.73%2.09M | 222.70%2.65M | 111.29%2.92M | 141.03%1.37M | -82.31%539.9K | -80.11%820.83K | 8.68%1.38M | -107.34%-3.35M | 99.31%3.05M | 215.01%4.13M |
| Net profit | 25.40%28.12M | 27.02%24.74M | 9.37%13.36M | 13.05%36.32M | 13.49%22.42M | 11.94%19.47M | -1.89%12.21M | -88.72%32.12M | -28.23%19.76M | -15.95%17.4M |
| Net profit from continuing operation | 25.40%28.12M | 27.02%24.74M | 9.37%13.36M | 13.05%36.32M | 13.49%22.42M | 11.94%19.47M | -1.89%12.21M | -88.72%32.12M | -28.23%19.76M | -15.95%17.4M |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 68.97%-324.59K | 53.90%-324.59K | 25.99%-324.59K |
| Net profit of parent company owners | 25.40%28.12M | 27.02%24.74M | 9.37%13.36M | 11.92%36.32M | 11.65%22.42M | 9.89%19.47M | -3.23%12.21M | -88.65%32.45M | -28.87%20.08M | -16.16%17.72M |
| Earning per share | ||||||||||
| Basic earning per share | 25.36%0.2343 | 26.99%0.2061 | 9.33%0.1113 | 11.91%0.3026 | 11.65%0.1869 | 9.88%0.1623 | -3.23%0.1018 | -88.65%0.2704 | -28.86%0.1674 | -16.13%0.1477 |
| Diluted earning per share | 25.36%0.2343 | 26.99%0.2061 | 9.33%0.1113 | 11.91%0.3026 | 11.65%0.1869 | 9.88%0.1623 | -3.23%0.1018 | -88.65%0.2704 | -28.86%0.1674 | -16.13%0.1477 |
| Other composite income | ||||||||||
| Total composite income | 25.40%28.12M | 27.02%24.74M | 9.37%13.36M | 13.05%36.32M | 13.49%22.42M | 11.94%19.47M | -1.89%12.21M | -88.72%32.12M | -28.23%19.76M | -15.95%17.4M |
| Total composite income of parent company owners | 25.40%28.12M | 27.02%24.74M | 9.37%13.36M | 11.92%36.32M | 11.65%22.42M | 9.89%19.47M | -3.23%12.21M | -88.65%32.45M | -28.87%20.08M | -16.16%17.72M |
| Total composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 68.97%-324.59K | 53.90%-324.59K | 25.99%-324.59K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
